Printer Friendly

TransEnterix to begin public offering of common stock.

Global Banking News-September 5, 2019-TransEnterix to begin public offering of common stock

(C)2019 ENPublishing - http://www.enpublishing.co.uk

Medical device company TransEnterix Inc (NYSE American:TRXC) on Wednesday announced the planned launch of its underwritten public offering of shares of its common stock.

The company proposes to provide the underwriter with a 30-day option to purchase up to another 15% of the shares of its common stock offered in the public offering.

All of the shares in the offering are to be sold by the company. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering, TransEnterix said.

Cantor Fitzgerald & Co is acting as sole book-running manager for the offering, which is subject to market and other conditions.

((Distributed via M2 Communications - http://www.m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Global Banking News (GBN)
Date:Sep 5, 2019
Words:144
Previous Article:GMS reports secondary public offering of 6,825,058 common shares.
Next Article:MPLX LP prices issue of USD2.0bn senior notes.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters